Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2024

Jul 31, 2024

60507_rns_2024-07-31_8992ea18-0a76-426f-ba93-6606e936e772.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

July 31, 2024

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”), we wish to inform you that, the Company has received an Order dated July 30, 2024, issued by the Proper Officer (State Tax), Commercial Tax Officer, Department of Commercial Tax, Karnataka, basis the GST audit conducted for Karnataka state for the financial year 2019-20 for a tax demand of Rs. 2,95,204/-, Interest of Rs. 2,19,390/- and penalty of Rs. 29,520/- aggregating to a total demand of Rs. 5,44,114/-.

Based on our assessment, we believe that the said demand is not maintainable, and the Company is in the process of preferring an appeal against the said Order. The Order has no material impact on the financials, operations or other activities of the Company.

Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure A.

Please take the same on record.

Thanking you,

Your truly, For Pfizer Limited

PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.07.31 20:59:57 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

ANNEXURE – A

Information as required under Regulation 30 - Part A of Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Sr.no. Particulars Details
1. Name
of
Authority
Initiating
the
action/passing the order.
Proper Officer (State Tax), Commercial Tax
Officer, Department of Commercial Tax,
Karnataka
2. Nature and details of the action(s) taken,
initiated or order(s) passed.
The Order received on July 30, 2024, under
section 73 of Goods & Services Tax Act, 2017
for a Tax Demand of Rs. 2,95,204/- (Rs. Two
Lakhs Ninety Five Thousand Two Hundred
Four Only) Interest of Rs. 2,19,390/- (Rs. Two
Lakhs Nineteen Thousand Three Hundred
Ninety Only) Penalty of Rs. 29,520/-
(Rs. Twenty Nine Thousand Five Hundred
Twenty Only) aggregating to a Total Demand
of Rs. 5,44,114/- (Rs. Five Lakhs Forty Four
Thousand One Hundred Fourteen Only)
3. Date of receipt of direction or Order,
including any ad-interim or Interim
Orders, or any other communication from
the authority
July 30, 2024
4. Details
of
the
violation(s)
/
contravention(s) committed or alleged to
be committed.
The Officer has raised the above GST
demand on account of alleged excess
availment of input tax credit.
5. Impact on financial, operation or other
activities of the listed entity, quantifiable
in monetary terms to the extent possible
Based on our assessment, we believe that
the said demand is not maintainable, and the
Company is in the process of preferring an
appeal against the said Order. The Order has
no material impact on the financials,
operations or other activities of the
Company.